GPR40 Attenuates Age-Related Macular Degeneration by Suppressing Retinal Microglial NLRP3 Inflammasome Activation Via

Xin Tan1,2,3, Jianshu Kang1,2, Hongkun Zhao1,2

  • 1Department of Ophthalmology, Yunnan Eye Institute & Key Laboratory of Yunnan Province, Yunnan Eye Disease Clinical Medical Center, Affiliated Hospital of Yunnan University, Yunnan University, Kunming, China.

Inflammation
|January 6, 2026
PubMed

Insights

G-protein-coupled receptor 40 (GPR40) activation shifts microglial cells to an anti-inflammatory state, protecting retinal cells. Targeting the GPR40-ERK pathway may treat age-related macular degeneration (AMD) and other retinal diseases.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Immunology

Background:

  • Retinal neuroinflammation, driven by microglial activation, is central to age-related macular degeneration (AMD).
  • The role of G-protein-coupled receptor 40 (GPR40) in AMD pathogenesis is currently unknown.

Purpose of the Study:

  • To investigate the role and mechanism of GPR40 in regulating retinal neuroinflammation in AMD.

Main Methods:

  • Established a sodium iodate-induced mouse model of non-exudative AMD.
  • Utilized in vitro experiments with lipopolysaccharide (LPS)-stimulated microglial cells.
  • Analyzed GPR40's effect on microglial polarization, ERK signaling, NLRP3 inflammasome activation, and cytokine release.

Main Results:

  • GPR40 activation promoted M2 anti-inflammatory microglial polarization, suppressing neuroinflammation.
  • GPR40 negatively regulated the ERK signaling pathway, inhibiting NLRP3 inflammasome activation and pro-inflammatory cytokine release (IL-1β, TNF-α).
  • GPR40 activation protected photoreceptors from neuroinflammation in vivo and in vitro.

Conclusions:

  • GPR40 plays a critical role in modulating retinal neuroinflammation via the GPR40-ERK signaling axis.
  • Targeting GPR40 offers a potential therapeutic strategy for AMD and other retinal degenerative diseases.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K